L, G., A, K., G, S., JH, B., S, P., Y, Q., . . . JK, G. (2025). Polatuzumab vedotin in CNS lymphoma: Proof-of-concept study for blood-brain barrier penetration. Blood advances, 9(24), 6425. https://doi.org/10.1182/bloodadvances.2025017181
Chicago Style (17th ed.) CitationL, Gao, et al. "Polatuzumab Vedotin in CNS Lymphoma: Proof-of-concept Study for Blood-brain Barrier Penetration." Blood Advances 9, no. 24 (2025): 6425. https://doi.org/10.1182/bloodadvances.2025017181.
MLA (9th ed.) CitationL, Gao, et al. "Polatuzumab Vedotin in CNS Lymphoma: Proof-of-concept Study for Blood-brain Barrier Penetration." Blood Advances, vol. 9, no. 24, 2025, p. 6425, https://doi.org/10.1182/bloodadvances.2025017181.
Warning: These citations may not always be 100% accurate.
